Malin Enblad
Specialist physician at Department of Surgical Sciences; Gastro intestinal Surgery
- E-mail:
- malin.enblad@uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA
More information is available to staff who log in.
Short presentation
This text is not available in English, therefore the Swedish version is shown.
Min forskning fokuserar på kolorektalcancer med spridning till bukhinnan och en variant av kolorektalcancer som kallas signetringcellscancer. Genom att kombinera molekylärbiologiska studier, populationsbaserade registerstudier och kliniska studier är målsättningen att förbättra vår kunskap om dessa ovanliga och aggressiva former av kolorektalcancer.
Publications
Selection of publications
- Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases - is routine omentectomy justified? (2024)
- No Indication for Routine Resection of Surgical Scars during Cytoreductive Surgery and HIPEC (2024)
- Prognostic genome and transcriptome signatures in colorectal cancers (2024)
- Next generation pan-cancer blood proteome profiling using proximity extension assay (2023)
- Signet Ring Cell Colorectal and Appendiceal Cancer (2023)
- Mucinous rectal cancers (2022)
- Oxaliplatin-based hyperthermic intraperitoneal chemotherapy with single drug versus multiple drug treatment for colorectal cancer with peritoneal metastases (2021)
- Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (2020)
- Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy (2020)
- Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC (2020)
- Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases (2019)
- Colorectal and appendiceal peritoneal metastases (2018)
- Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (2018)
- Risk factors for appendiceal and colorectal peritoneal metastases (2018)
- Increased incidence of bowel cancer after non-surgical treatment of appendicitis (2017)
- Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (2016)
- Prognostic whole-genome and transcriptome signatures in colorectal cancers
Recent publications
- Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases - is routine omentectomy justified? (2024)
- No Indication for Routine Resection of Surgical Scars during Cytoreductive Surgery and HIPEC (2024)
- Prognostic genome and transcriptome signatures in colorectal cancers (2024)
- Next generation pan-cancer blood proteome profiling using proximity extension assay (2023)
- Signet Ring Cell Colorectal and Appendiceal Cancer (2023)
All publications
Articles
- Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases - is routine omentectomy justified? (2024)
- No Indication for Routine Resection of Surgical Scars during Cytoreductive Surgery and HIPEC (2024)
- Prognostic genome and transcriptome signatures in colorectal cancers (2024)
- Next generation pan-cancer blood proteome profiling using proximity extension assay (2023)
- Signet Ring Cell Colorectal and Appendiceal Cancer (2023)
- Mucinous rectal cancers (2022)
- Oxaliplatin-based hyperthermic intraperitoneal chemotherapy with single drug versus multiple drug treatment for colorectal cancer with peritoneal metastases (2021)
- Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (2020)
- Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy (2020)
- Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC (2020)
- Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases (2019)
- Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (2018)
- Risk factors for appendiceal and colorectal peritoneal metastases (2018)
- Increased incidence of bowel cancer after non-surgical treatment of appendicitis (2017)
- Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (2016)
- Prognostic importance of genetic alterations in colorectal peritoneal metastases
- Prognostic whole-genome and transcriptome signatures in colorectal cancers
Books
